These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6376022)

  • 41. Naturally improving insulin resistance with amorfrutins.
    Lefebvre P; Staels B
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7136-7. PubMed ID: 22543162
    [No Abstract]   [Full Text] [Related]  

  • 42. Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop.
    Barrett JS; Bucci-Rechtweg C; Amy Cheung SY; Gamalo-Siebers M; Haertter S; Karres J; Marquard J; Mulugeta Y; Ollivier C; Strougo A; Yanoff L; Yao L; Zeitler P
    Clin Pharmacol Ther; 2020 Jul; 108(1):29-39. PubMed ID: 32017043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between the mechanism of action of the sulfonylureas and the secretion of insulin into the portal circulation.
    MADISON LL; COMBES B; UNGER RH; KAPLAN N
    Ann N Y Acad Sci; 1959 Mar; 74(3):548-56. PubMed ID: 13637593
    [No Abstract]   [Full Text] [Related]  

  • 44. Neurogastroenterology: Improving glucose tolerance via the gut-brain axis.
    Weber C
    Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):4. PubMed ID: 26627551
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pharmacotherapeutic reviews. XXII. Insulin and oral antidiabetics].
    Ned Tijdschr Geneeskd; 1966 Apr; 110(14):684-8. PubMed ID: 5327735
    [No Abstract]   [Full Text] [Related]  

  • 46. Speculations on the action of insulin, with a note on other hypoglycemic agents.
    KRAHL ME
    Perspect Biol Med; 1957; 1(1):69-96. PubMed ID: 13484381
    [No Abstract]   [Full Text] [Related]  

  • 47. Loss of pulsatile insulin secretion: a factor in the pathogenesis of type 2 diabetes?
    Wahren J; Kallas Å
    Diabetes; 2012 Sep; 61(9):2228-9. PubMed ID: 22923651
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin and receptors. Edited papers based on a symposium of the 8th International Congress of Endocrinology. Kobe, Japan, 14-15 July 1988.
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S1-S118. PubMed ID: 2680361
    [No Abstract]   [Full Text] [Related]  

  • 49. [Observations on oral antidiabetics].
    Verhagen H
    Ned Tijdschr Geneeskd; 1966 Oct; 110(41):1793-8. PubMed ID: 5977130
    [No Abstract]   [Full Text] [Related]  

  • 50. [Not Available].
    Arditi C; Labud H; Roulet L; Zanchi A; Peytremann-Bridevaux I
    Rev Med Suisse; 2021 Jun; 17(744):1237. PubMed ID: 34160923
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral hypoglycemic agents.
    Seidensticker JF; Hamwi GJ
    Geriatrics; 1967 May; 22(5):112-24. PubMed ID: 5337295
    [No Abstract]   [Full Text] [Related]  

  • 52. Obesity: glypican-4: role in insulin signalling.
    Mitchell F
    Nat Rev Endocrinol; 2012 Sep; 8(9):505. PubMed ID: 22825400
    [No Abstract]   [Full Text] [Related]  

  • 53. Proceedings of the Xth International Symposium on Insulin Receptors and Insulin Action. May 2-6, 2007. Stockholm, Sweden.
    Acta Physiol (Oxf); 2008 Jan; 192(1):1-135. PubMed ID: 18618936
    [No Abstract]   [Full Text] [Related]  

  • 54. The current role of insulin in the era of hypoglycemic agents.
    HAUNZ EA
    Am Pract Dig Treat; 1962 Jan; 13():3-15. PubMed ID: 13905413
    [No Abstract]   [Full Text] [Related]  

  • 55. Big deal about a little insulin.
    Flier JS
    Nat Med; 1999 Jun; 5(6):614-5. PubMed ID: 10371493
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapy with oral antidiabetics 1983].
    Berchtold P; Berger M
    Ther Umsch; 1983 Oct; 40(10):883-90. PubMed ID: 6359559
    [No Abstract]   [Full Text] [Related]  

  • 57. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG; Olefsky JM
    Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symposium of oral hypoglycemic agents on receptor and postreceptor actin of insulin.
    Diabetes Care; 1984; 7 Suppl 1():1-129. PubMed ID: 6376022
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.